These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16456219)

  • 1. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
    Bhanji NH; Chouinard G; Kolivakis T; Margolese HC
    Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioridazine withdrawal-induced behavioral deterioration treated with clonidine: two case reports.
    Sovner R
    Ment Retard; 1995 Aug; 33(4):221-5. PubMed ID: 7565144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Withdrawal reactions after clomipramine].
    Zemishlany Z; Aizenberg D; Hermesh H; Weizman A
    Harefuah; 1992 Oct; 123(7-8):252-5, 307. PubMed ID: 1459499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebound insomnia in neuroleptic drug withdrawal neurophysiologic characteristics.
    van Sweden B
    Pharmacopsychiatry; 1987 May; 20(3):116-9. PubMed ID: 2885865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological distress and adaptational problems associated with benzodiazepine withdrawal and outcome: a replication.
    O'Connor KP; Marchand A; Bélanger L; Mainguy N; Landry P; Savard P; Turcotte J; Dupuis G; Harel F; Lachance L
    Addict Behav; 2004 May; 29(3):583-93. PubMed ID: 15050676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coincidence of anxiety and sleep disorders. Overview and case reports].
    Hajak G; Bandelow B
    Fortschr Neurol Psychiatr; 1996 Jan; 64(1):26-40. PubMed ID: 8850093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The abrupt discontinuation of fluvoxamine in patients with panic disorder.
    Black DW; Wesner R; Gabel J
    J Clin Psychiatry; 1993 Apr; 54(4):146-9. PubMed ID: 8486592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Side effects of benzodiazepines: "rebound" anxiety and insomnia].
    Pesce A; Rossi F; Valeri P
    Clin Ter; 1981 Dec; 99(5):461-70. PubMed ID: 7037272
    [No Abstract]   [Full Text] [Related]  

  • 9. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
    Chouinard G
    J Clin Psychiatry; 2004; 65 Suppl 5():7-12. PubMed ID: 15078112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine in panic disorder: clinical management and long-term follow-up.
    Dannon PN; Lowengrub K; Iancu I; Kotler M
    Expert Rev Neurother; 2004 Mar; 4(2):191-8. PubMed ID: 15853560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal akathisia: case reports and a proposed classification of chronic akathisia.
    Lang AE
    Mov Disord; 1994 Mar; 9(2):188-92. PubMed ID: 8196681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders.
    Yasui-Furukori N; Kaneko S
    Psychiatry Clin Neurosci; 2011 Jun; 65(4):384-5. PubMed ID: 21489048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of paroxetine with clocapramine in panic disorder.
    Saito M; Miyaoka H
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):449. PubMed ID: 17610675
    [No Abstract]   [Full Text] [Related]  

  • 14. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Benzodiazepine withdrawal syndrome. Problems of differential diagnosis against depression, panic attacks and generalized anxiety].
    Petracca A; Michelini S; Perugi G; Cassano GB
    Clin Ter; 1991 May; 137(3):191-7. PubMed ID: 1831087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebound insomnia after abrupt clozapine withdrawal.
    Staedt J; Stoppe G; Hajak G; Ruther E
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(2):79-82. PubMed ID: 9063912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P; Nir T; Laudon M; Zisapel N
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute nicotine withdrawal symptoms and anxious responding to bodily sensations: a test of incremental predictive validity among young adult regular smokers.
    Zvolensky MJ; Feldner MT; Leen-Feldner EW; Gibson LE; Abrams K; Gregor K
    Behav Res Ther; 2005 Dec; 43(12):1683-700. PubMed ID: 16239158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.